IGO Ltd

Phase A — Understand the business

Company Overview

IGO Ltd is a Perth-based ASX-listed miner that, after a brutal two-year self-reinvention, is now essentially a single-asset, no-control lithium royalty wrapped in a winding-down nickel business. Stripped to its economics, IGO is three things stacked on top of each other:

1. The crown jewel — 24.99% indirect economic interest in Greenbushes. Through the Tianqi Lithium Energy Australia (TLEA) joint venture, IGO holds an indirect 24.99% economic interest in the Greenbushes Lithium Operation in Western Australia. Greenbushes is the largest and lowest-cost hard-rock lithium mine on Earth, supplying >20% of global high-grade lithium concentrate. The ownership chain: TLEA (Tianqi 51% / IGO 49%) owns 51% of Talison Lithium, which owns Greenbushes; Albemarle owns the other 49% of Talison. Net to IGO: 49% × 51% = 24.99% of the mine's economics. This stake is the overwhelming majority of IGO's intrinsic value.

2. The albatross — 49% indirect interest in the Kwinana Lithium Hydroxide Refinery. TLEA owns 100% of Kwinana; IGO's 49% of TLEA gives it a 49% indirect interest. Kwinana was meant to capture downstream lithium-chemical margin. Instead, after three years of operation it reached only ~35% of nameplate capacity, IGO recorded a A$605M full impairment in FY25 (plus A$58M de-recognition of related deferred tax assets), Vella has said publicly "it is just not working" and "we don't see that pathway there," and IGO is in talks with Tianqi over a full exit. Crucially, Tianqi has confirmed it intends to retain control and is not shutting Kwinana down, and TLEA suspended Train 2 construction in January — so IGO can leave only on Tianqi's terms, if at all.

3. The wind-down — 100%-owned nickel. The Nova nickel-copper-cobalt mine (Fraser Range, WA) is IGO's only wholly-owned producing operation and reaches end-of-life by late calendar-2026; rehabilitation works begin in 2027 as a multi-year program. Forrestania ceased production Sept-2024 and was sold to Medallion Metals for zero cash consideration (Medallion took the plant + rehabilitation liabilities) in early 2026. Cosmos — into which IGO sank A$500M+ — was mothballed (care & maintenance) in June-2024.

How it makes money. IGO's reported revenue is overwhelmingly Nova nickel concentrate sales (FY25 nickel revenue A$512M, down from A$823M FY24 ); the lithium economics flow through equity accounting — IGO's share of TLEA's net profit, plus distributions/dividends from Talison out of free cash flowFree cash flowCash left after paying to run and maintain the business. Unlike profit, it is hard to flatter with accounting choices. — not consolidated revenue. This is the single most important structural fact about reading IGO: the asset that matters does not show up in the revenue line. It appears as "share of profit of associates" + cash distributions. So "IGO revenue" understates the business and "IGO EBITDA" is distorted — it bundles consolidated nickel losses while excluding the unconsolidated lithium profits IGO actually owns.

Customers / suppliers / competitors. End customers for Greenbushes spodumene are lithium converters — Tianqi and Albemarle take Greenbushes offtake at the Talison level, increasingly priced off a more frequently-reset (near-spot) formula. Nova nickel concentrate goes to a small set of offtake counterparties. Suppliers are standard mining inputs (diesel, reagents, mining contractors, grid power). Competitors as an investable lithium vehicle: Pilbara Minerals (PLS), Mineral Resources (MIN), Liontown (LTR) on the ASX, plus Albemarle and SQM globally (our figures empty — n/a in research layer).

Contract structure. No take-or-pay; spodumene priced off a frequently-reset formula tied to lithium-chemical prices. The most important "contract" is really the JV governance with Tianqi and Albemarle — IGO is a minority at every level (24.99% of the mine, 49% of TLEA) and therefore does not control its single most valuable asset. That is a structural governance fact, not a footnote.

Supply Chain

Named, end-to-end. Spodumene → hydroxide/carbonate → cathode → cell → EV/ESS.

Upstream inputs → mine. Diesel, grinding media, flotation reagents, electricity (SW Interconnected System, WA), and mining contractors feed the Greenbushes open pit. Greenbushes is a hard-rock pegmatite; the CY25 Mineral Resource is 457Mt at 1.6% Li₂O (+4% mass / +9% contained Li₂O vs CY24) — but 2025 mined feed was 6.16Mt of ore at 1.9% Li₂O producing ~1.35Mt of concentrate. The gap between the ~1.9% being mined and the ~1.6% resource average is the quantified shape of the grade-decline story (see Lens 5).

The asset and its owners.

• Greenbushes mine → operated by Talison Lithium → owned 51% by TLEA (Tianqi 51% / IGO 49%) and 49% by Albemarle.
• Kwinana refinery → 100% TLEA (so 49% IGO / 51% Tianqi); Train 2 construction suspended Jan-2026.
• Nova mine → 100% IGO (sole producing wholly-owned op, end-of-life late-2026, rehab from 2027).

Midstream — conversion. Greenbushes spodumene (SC6, ~6% Li₂O concentrate) is shipped to converters. Offtake is split between the two JV strategics — Tianqi (China hydroxide/carbonate plants incl. Kwinana) and Albemarle (Kemerton, WA + global). Kwinana itself is the would-be domestic conversion node — and the broken link in the chain.

Downstream — cathode/cell/end-market. Hydroxide/carbonate → cathode active material (largely China) → cell makers (CATL, LG Energy Solution, Panasonic, BYD) → EVEnterprise valueWhat it would cost to buy the whole company: its market value plus its debt, minus the cash you would get with it. Often very different from market cap. OEMs + grid ESS. IGO has no presence below the refinery — its exposure ends at the spodumene/hydroxide gate.

Chokepoints / single-source dependencies.

• Single-asset concentration: Greenbushes is the company's value. One orebody, one geology, one set of operating risks. The June-2026 CGP3 fire and the structural feed-grade decline are not diversifiable away.
• Minority-control chokepoint: IGO can't unilaterally direct capexCapital expenditureMoney spent on long-lived things — buildings, machines, servers — rather than on running costs., dividend timing, offtake terms, or strategy at Greenbushes/Kwinana — Tianqi (controlling 51% of TLEA) and Albemarle (49% of Talison) hold the levers. The Kwinana exit, tellingly, requires Tianqi's agreement, and Tianqi has said it wants to keep control.
• Geographic concentration: essentially 100% Western Australia — same jurisdiction, same labour market, same power grid, same WA royalty/regulatory regime.
• Customer concentration in conversion: Greenbushes offtake is concentrated in two converters (Tianqi, Albemarle), one of which (Tianqi) is also IGO's controlling JV partner — an alignment that is a strength in good times and a conflict in a dispute.

Competitive Advantages (moats)

The moat is the orebody, and it is real — but it is not IGO's moat, it is Greenbushes'. Greenbushes has a genuine, durable cost moat: it is the lowest-cost hard-rock lithium mine globally, posting a 66% EBITDA margin in FY25 (down from 85% in FY24) and ~75% in the March-2026 quarter even at suppressed spodumene prices. At the trough of the worst lithium bust in a decade, Greenbushes still generated ~A$1.5B of operating cash flow. That is a first-quartile — arguably first-decile — cost-curve position: the rare mining asset that earns above its cost of capital across the cycle. Moat sources: exceptional mined grade (~1.9% Li₂O vs ~1.0–1.3% for most peers), scale, integrated processing, and 40+ years of operating know-how.

But IGO's own moat is thin-to-nonexistent. Strip out Greenbushes and IGO is a sub-scale nickel miner in terminal decline plus a refinery it is trying to give away. The investable question is not "does IGO have a moat" — it's "is owning 24.99% of a great asset, with no control, at a public-market multiple, a good way to own that asset?" That is structurally weaker than owning the asset outright — which Albemarle and Tianqi effectively do.

Bargaining power.

• Over suppliers: modest — standard mining-services market, no special leverage.
• Over customers: the bargaining power sits with Greenbushes/Talison (a must-have, lowest-cost source of >20% of global high-grade concentrate), not with IGO the holding company. IGO captures that power only pro-rata and only with JV-partner consent.
• Within the JV: IGO is the junior partner. Tianqi controls TLEA; Albemarle co-controls Talison. IGO is a minority financial participant in its own crown jewel. This is the central governance weakness of the equity.

Switching costs / network effects / IP: none meaningful at the IGO level. The durable advantage is purely the geological endowment of one mine, shared three ways — and that endowment is grading down.

Segments

our figures is empty in the research layer — all figures below are, on a 100%-asset basis (i.e. before applying IGO's 24.99%/49% economic share), which is how IGO reports JV-asset performance.

Geography: ~100% Western Australia. No meaningful geographic segmentation.

Group result FY25: statutory net loss after tax A$955M (vs A$3M profit FY24); underlying EBITDA −A$43M (vs +A$581M FY24). Provenance conflict flagged: one outlet (mining-technology.com / Yahoo) reports the FY25 net loss as A$619M rather than A$955M — the A$955M figure (IGO's own FY25 presentation, Mining Weekly, Australian Mining Review) appears to be the headline statutory loss attributable to members, while the A$619M may be a pre-some-items measure; not silently reconciled — both reported. The impairment stack behind the loss: A$605M Kwinana + A$58M Kwinana DTA + A$115M exploration write-off + A$58M increase in Nova/Cosmos/Forrestania rehab provisions. The swing from +A$581M to −A$43M underlying EBITDA in one year is the violence of a single-commodity downturn hitting a portfolio with no diversification left.

The read on the trend: Greenbushes decelerated hard but stayed massively profitable; everything else around it bled. The FY25 loss was manufactured by IGO's own non-Greenbushes assets (Kwinana + nickel/exploration impairments), not by the crown jewel. The 1H FY26 print confirms the inflection: net loss narrowed 96% to A$34.1M, underlying EBITDA +A$49M, IGO's share of TLEA net loss improved to just −A$1M (from −A$20M), Greenbushes 100%-basis EBITDA A$464M for the half. The business is turning the corner as lithium prices recover.

---

Phase B — Measure performance

Earnings Result (latest: 1H FY26 half to 31-Dec-2025; + Q3 FY26 quarterly to Mar-2026)

1H FY26 (reported 19-Feb-2026) — the inflection print:

• Net loss A$34.1M, narrowed 96% vs 1H FY25.
• Underlying EBITDA +A$49M (group) — back in the black at the underlying line.
• Greenbushes EBITDA A$464M (100% basis) for the half — "extraordinary low-cost position even at suppressed spodumene prices".
• IGO's share of TLEA underlying net loss improved to −A$1M (from −A$20M prior half) — the lithium JV is essentially at breakeven and turning.
• Kwinana still loss-making: ~−A$71M (100% basis) for the half, fully impaired.
• Nova EBITDA ~A$67M, up on prior period on better realised nickel prices.
• Net cash A$299M at 31-Dec-2025; strengthened to A$327M at 31-Mar-2026 (Q3 FY26). Essentially debt-free (revolving facility reduced to A$300M, undrawn, maturity Jul-2028); the ~A$900M Western Areas acquisition debt has been cleared.
• No interim dividend.

Q3 FY26 quarterly (to 31-Mar-2026):

• Realised spodumene price US$1,668/t — nearly double the prior quarter.
• Greenbushes maintained ~75% EBITDA margin on higher price.
• This is the quarter where the lithium recovery shows up in the numbers — and the quarter whose production miss triggered the guidance cut below.

vs consensus: no clean consensus beat/miss figure is sourceable — n/a. The market reaction tells the story instead.

Guidance & the tone shift — the critical negative. On 24-April-2026 IGO cut FY26 Greenbushes guidance: spodumene production to 1.375–1.425Mt (from 1.5–1.65Mt, ~−11% at midpoint) and unit cash cost to A$380–420/t (from A$310–360/t, ~+19–25%). MD Ivan Vella called the quarter "disappointing" and said performance had been challenged across safety, feed grade, recoveries, maintenance execution and plant reliability, with "many of these issues are systemic". This is the single most important sentence in the file: the crown jewel is showing structural, not transitory, operating stress — and the mechanism (lower feed grade → more ore through the plant for the same concentrate → strain on reliability) is geological, not a one-off.

Balance-sheet flags: clean. Net cash A$327M, negligible debt, Kwinana impairment already taken (the bad news is on the page, not hiding). Inventory/receivables detail not separately sourceable (n/a). The risk is operational/asset, not financial leverage.

Market reaction: two regimes. (1) The April-2026 "systemic problems" guidance cut triggered an ~18% single-day fall to A$7.01 — the worst in over a decade. (2) Yet over the trailing year the stock is up ~124% on the lithium-price recovery, last around A$9.25 versus a 52-wk high of A$10.05. The tape says: the macro (lithium price) dominates the micro (Greenbushes operating cracks) — for now.

Earnings Calls (sentiment trend)

transcripts/ empty — -sourced from call/results summaries.

Arc of management messaging, FY24 → Q3 FY26:

• FY24 / Sept-2024 (Vella's first full strategy reset): "lithium at the core, nickel and copper as supports" — a deliberate pivot away from the nickel identity IGO was built on. Tone: contrite about nickel, evangelical about Greenbushes.
• FY25 (Aug-2025): owning a A$955M loss — tone of "trough of the cycle, world-class asset will carry us through," heavy emphasis on Greenbushes' 66% margin and ~A$1.5B cash generation at the bottom.
• 1H26 (Feb-2026): markedly more constructive — "strong cash flow and lithium-market boost," net cash building, losses narrowing 96%, TLEA near breakeven. The relief is audible.
• Q3 FY26 (Apr-2026) + the guidance cut: the whiplash — same quarter shows doubled realised price and the "systemic problems" admission. Management forced to concede Greenbushes' issues are deeper than one-off.

Recurring phrases: "world-class asset," "lowest-cost hard-rock lithium," "through the cycle," "disciplined capital allocation," "portfolio rationalisation." What they stopped saying: the bullish multi-asset nickel-growth language of the 2021–22 Western Areas era. "Nickel" has gone from thesis → liability → exit.

Net sentiment read: improving on the macro, but with a fresh and serious crack of candour about the crown jewel's operating health. Management credibility is recovering but not restored — they are still cleaning up the prior team's mess while now having to explain new problems at the one asset that was supposed to be bulletproof.

Comps

Sector context + the analyst split. Large-cap ASX lithium is trading ~6.7x (PLS) down to ~2.0x (LTR) on forward EV/EBITDA, with the spread "almost entirely a function of the assumed long-run spodumene price". Macquarie's stance is instructive: Neutral on PLS, Underperform on MIN and LTR, while framing IGO as the name whose FY27 earnings roughly triple on the price recovery.

The read — and the trap. IGO screens "cheapest" at 2.7x. But that headline is misleading: IGO's reported EBITDA is contaminated by consolidated nickel (being wound to zero) and excludes the equity-accounted Greenbushes profit it actually owns. A clean comparison values IGO as net cash (~A$327M) + 24.99% of Greenbushes' value + 49% of a ~zero-value Kwinana − closure/rehab liabilities − corporate overhead. On a look-through basis IGO is not obviously the cheapest in the group — it is a stub on one asset. Macquarie's framing is the honest one: the appeal is lithium-price torque (FY27 earnings tripling), not IGO being structurally undervalued versus PLS.

Stock-Price Catalysts (moves >5%, last ~5 years)

Mostly.

• 2021 (TLEA deal, ~US$1.4B): IGO buys into Greenbushes + Kwinana — the strategic pivot that defines today's company.
• 2022 (Western Areas, ~A$1.1B all-cash, ~A$3.87/sh): IGO doubles down on nickel near the top of the nickel market. (In hindsight, the value-destruction catalyst.)
• 2022 (lithium peak, spodumene ~US$8,000/t): stock rides the battery-metals mania to highs.
• 2023–early 2025 (battery-metals bust): lithium <US$1,000/t for 18+ months; IGO ~−78–80% from Jul-2023 to Apr-2025. Nickel impairments (Cosmos/Forrestania ~A$1B in FY23) compound the pain.
• 2024 (nickel capitulation): Cosmos mothballed (Jun-2024), Forrestania ceases (Sep-2024).
• 2025 (FY25, A$955M loss + A$605M Kwinana write-off): the kitchen-sink year.
• Late-2025 → 2026 (lithium recovery): battery-grade carbonate roughly doubles to ~US$26,278/t in Q1-2026; realised spodumene to US$1,668/t; stock +~124% over the trailing year.
• 24-April-2026 (Greenbushes "systemic problems" guidance cut): ~−18% in a day to A$7.01, worst in 10+ years.
• 9-June-2026 (CGP3 fire): lithium futures spiked intraday; IGO trading near a 52-wk high (range A$3.74–10.05); FY26 production guidance maintained.

What the pattern reveals: IGO trades as a high-beta proxy on the spodumene price, full stop. Idiosyncratic news (M&A, impairments, even a fire at the crown jewel) moves it, but the dominant variable by an order of magnitude is the lithium price. Buy/sell IGO and you are really making a lithium-price call with operating and governance leverage bolted on. The April-2026 fall is the one telling exception: when the crown jewel itself is the bad news (not the macro), the market punishes it hard — then forgot about it weeks later when the fire spiked prices.

---

Phase C — Judge people & books

Management

CEO/MD — Ivan Vella (appointed Dec-2023, ~2.5yr tenure).

• Track record: ~20 years at Rio Tinto, rising to Chief Executive, Aluminium and a Rio executive-committee member — a genuine major-miner operator, not a promoter. He inherited the wreckage (the TLEA/Western Areas bets were made by predecessor Peter Bradford) and his job has been damage control + refocusing on lithium.
• What he's actually done: executed the strategic reset (lithium core; nickel "support" → now exit), took the kitchen-sink FY25 impairments, cleared the Western Areas debt to net cash, off-loaded Forrestania for A$0, mothballed Cosmos, and opened the Kwinana exit discussions. A credible, disciplined clean-up. He is not the architect of the value destruction — he is the receiver.
• Capital-allocation history (the company's, pre-Vella): poor. The defining moves — TLEA (2021, fine in hindsight) and Western Areas (2022, ~A$1.1B at the nickel top, financed with ~A$900M debt) — bracket a classic late-cycle commodity miner buying high. Cosmos alone consumed A$500M+ before being mothballed; Forrestania ultimately handed away for A$0; Kwinana A$605M impaired ("just not working"). Dividend suspended after a A$197M FY24 payout. A multi-year record of value destruction the current team is unwinding.
• Tenure & skin in the game: Vella ~2.5yr; insider-ownership figure n/a (our figures absent). The finance function is a live red flag: Kathleen Bozanic → Ian Rowe (interim) → Johan van Vuuren appointed effective 1-Apr-2026 — who then resigned effective 29-Apr-2026, after under a month ("the role was not the right fit for his career aspirations"). That is four CFO events in ~two years, one lasting 29 days. Even if benign, a CFO walking inside a month, weeks after the worst single-day share fall in a decade, is the kind of finance-function instability that demands scrutiny.
• Founder vs professional manager: thoroughly professional-manager (ex-Rio). Implication: expect disciplined operating + portfolio rationalisation, not founder-style swing-for-the-fences bets. Appropriate for a turnaround/clean-up stage.

Net: a competent, credible cleanup operator running a company whose prior leadership destroyed substantial capital — but now carrying a visibly unstable finance function. The bet on management is a bet that Vella can (a) extract IGO cleanly from Kwinana (on Tianqi's terms), (b) close nickel without ugly rehab surprises, (c) actually manage the newly-disclosed structural problems at Greenbushes (largely outside his control as a 24.99% minority), and (d) stabilise the CFO seat.

Forensic Red Flags

our figures empty — figures; this lens is necessarily lighter than a filing-grounded one. Flagged honestly as such.

Accounting / disclosure risk areas:

1. Equity-accounting opacity (the big one). IGO's most valuable asset (Greenbushes) and its worst (Kwinana) both sit off the consolidated revenue line, inside the TLEA associate. Investors see "share of profit of associates" + distributions, not the underlying P&L — so reported group revenue/EBITDA is structurally unrepresentative of the real economics. Not fraud; a legibility risk that makes screening multiples (Lens 7) actively misleading.
2. Headline-loss discrepancy. FY25 net loss reported as A$955M (IGO presentation / Mining Weekly) vs A$619M (mining-technology.com / Yahoo) — surfaced explicitly, not reconciled. A diligence item: confirm which is statutory loss attributable to members.
3. Impairment cadence. ~A$1B nickel impairments (FY23) + A$605M Kwinana + A$58M Kwinana DTA + A$115M exploration (FY25). Serial large impairments are a fingerprint of past over-payment (Western Areas, Cosmos). The good news: they're taken — Kwinana now carried at ~zero, so that downside is recognised.
4. Rehabilitation / closure liabilities. Nova closure (rehab from 2027, multi-year), Cosmos C&M, Forrestania liabilities transferred to Medallion. FY25 already added A$58M to the Nova/Cosmos/Forrestania rehab provision, but the total provision and its cash-outflow profile are n/a — a key diligence item, and a classic place for nickel-miner under-provisioning.
5. CFO turnover / control risk (four CFO events ~2024–2026, one of 29 days) — worth watching for any restatement/internal-control matters, though more likely finance-function churn than an accounting problem.
6. Cash-flow vs earnings: at the asset level, Greenbushes shows strong cash conversion (66% margin, ~A$1.5B operating cash flow at the trough ) — a positive tell, not a red flag. Group FCF/inventory/receivables detail n/a.
7. SBC / non-GAAP: "underlying EBITDA" excludes the impairments — standard for miners but means underlying and statutory diverge by ~A$900M in FY25. Read statutory.

Regulatory findings (required sub-section).

• SEC (EDGAR LR + AAER): zero findings. IGO has no CIK and does not file with the SEC, so no EDGAR enforcement search is possible. The regulatory file confirms total_sec_findings: 0.
• Non-SEC enforcement (web search): No material FTC/DOJ/FDA/CFPB-type actions apply — IGO is an Australian miner; the relevant regulators are ASIC, the ASX, and WA DMIRS/WorkSafe. The 9-June-2026 Greenbushes CGP3 fire is under investigation by Talison and falls under WA work-safety oversight — an operational/safety matter, not a securities/financial-fraud enforcement action. No securities-enforcement hits surfaced.
• Item 3 / Legal Proceedings: no US 10-KForm 10-KA company’s audited annual report to the US regulator. The most complete thing it publishes. exists (no EDGAR filer). The equivalent — contingencies/legal notes in IGO's FY25 Annual Report — was not ingested as a primary filing this run; n/a for specific litigation.
• Bottom line: No material securities-fraud or financial-enforcement findings identified via SEC EDGAR (zero, by structural exemption) and web search as of 2026-06-30. Caveat: absence of evidence here is partly a function of IGO being outside the SEC perimeter — a thorough diligence pass would query ASIC and ASX disclosure records directly, which this web-only run did not reach.

---

Phase D — Project & stress-test

Forward Projection (FY26 → FY28; AUD)

Web-only, no our figures, no our figures EPS line — so this is a **directional ** built from sourced inputs, not a precise bottom-up model. EPS sensitivity to the spodumene price is enormous; I express the projection as scenarios on realised SC6 price, the one variable that matters. No our model create is run (watchlist/unattended rule + the projection is too price-dependent to commit a Brier point honestly).

Anchor facts: ~757M shares; net cash A$327M at 31-Mar-2026; FY26 Greenbushes production guidance 1.375–1.425Mt @ A$380–420/t cash cost; IGO's economic share = 24.99%; Nova contributes through ~late-2026 then →0 (rehab cash out from 2027); Kwinana ≈ breakeven-to-loss, treated as ~zero value; dividend suspended.

Macro backdrop is now two-sided and tilting bullish on spodumene specifically. Fastmarkets raised its 2026 lithium forecast to US$23.80/kg (from US$17.40) and 2027 to US$31.40/kg (from US$22.65), and sees a structural spodumene deficit in 2026 (converter overcapacity, Australian curtailments, Jiangxi/Jianxiawo lepidolite suspensions). But the dispersion is real: BMI expects the broad lithium market to stay in surplus to 2029 before a 2030s deficit. So the bull and bear scenarios below are both live.

Specific EPS figures: n/a (no clean consensus EPS line obtained; declining to fabricate one). The honest projection statement: IGO's three-year earnings are a leveraged function of the spodumene price × 24.99% of Greenbushes' (now grade-impaired, higher-cost) volumes, plus a net-cash cushion, minus a winding-down nickel business and a ~zero refinery. Base case (US$1,500 SC6) = clear return to profit in FY26 and a ~3x FY27 earnings jump — that is consensus, not contrarian.

Bull vs Bear

Bull case. You are buying 24.99% of the single best hard-rock lithium asset on the planet at a moment when the lithium price has decisively turned (carbonate ~doubled to ~US$26.3k/t; SC6 to US$1,668/t ) and the company is already debt-free with A$327M net cash. Greenbushes earns above WACC even at the trough (66% margin, ~A$1.5B cash flow at the bottom ). The nickel albatross is nearly gone; Kwinana is fully impaired (downside recognised). If spodumene runs to deficit on ESS + EV demand, IGO is high-torque, balance-sheet-safe exposure with FY27 earnings tripling and a probable dividend resumption. The market re-rated it ~124% and it can still work if the cycle has legs.

Bear case (the permanent-impairment risks).

1. The crown jewel is structurally degrading. Greenbushes' April-2026 guidance cut was explicitly "systemic" — feed-grade decline, recovery rates, plant reliability and safety. The numbers make it concrete: 2025 mined feed ~1.9% Li₂O against a CY25 resource average of just 1.6% — the mined grade is converging down toward the resource, and grade decline is geological and permanent: every future tonne costs more and yields less. The June-2026 CGP3 fire at the very plant meant to add 500ktpa of growth underlines execution/asset risk at the one thing that matters. If Greenbushes' cost moat erodes from first-decile toward mid-curve, the entire thesis weakens.
2. No control + a sole proxy on a volatile commodity. IGO owns 24.99% with no operating control; Tianqi (51% of TLEA) and Albemarle hold the levers — including consent over a Kwinana exit Tianqi has said it doesn't want. You bear full lithium-price volatility while a JV partner steers. Lithium is the most violently cyclical battery metal (US$8,000 → <US$1,000 → recovering within four years), and BMI still sees broad surplus to 2029.
3. The recovery is in the price. At ~A$9.25 (near a 52-wk high of A$10.05, +124% in a year), the easy re-rate is done; analyst consensus PTConsensus price targetThe average of what published analysts think the share price should be. An opinion poll, not a forecast. (~A$8.37) sits below the price. Base-case "earnings triple in FY27" assumes SC6 holds ~US$1,500. If the bounce is a supply-disruption head-fake (Greenbushes-fire spike, Chinese oversupply still looming) rather than durable demand-led deficit, IGO gives back a large share of the rally.

Pre-mortem (18 months out, thesis broke — what happened?): Lithium rolled over again (Chinese lepidolite restarts + African supply + slowing EV growth overwhelmed ESS demand, vindicating BMI's surplus call); SC6 fell back toward US$1,000. Simultaneously Greenbushes' "systemic" problems proved persistent — grade decline + post-fire CGP3 delays kept volumes low and unit costs high — so IGO got the worst of both: a falling price on shrinking, costlier volumes. Nickel closure threw up rehab cost surprises and the CFO seat stayed unstable. The 124% re-rate unwound and IGO round-tripped toward A$4–6.

Are multiples too high? Headline 2.7x EV/EBITDA looks cheap but is contaminated (Lens 7). On a clean look-through, after the 124% run, IGO is fairly-to-fully valued for the base case — not cheap optionality anymore; a consensus lithium-recovery long with asset-specific cracks, trading slightly above the analyst consensus PT.

Contrarian view (what the market is refusing to see): The market is treating IGO as a clean leveraged lithium proxy and rewarding it accordingly — while quietly ignoring that the crown jewel itself just told you its problems are structural, not cyclical. The bull narrative ("world-class lowest-cost asset, buy the cycle") is fighting a slow, permanent erosion of the very cost advantage that defines the asset — visible in the 1.9%→1.6% grade convergence. The April-2026 18% one-day fall was the market briefly seeing it, then forgetting as the fire spiked prices. Greenbushes getting permanently more expensive to run is the under-priced risk.

Devil's Advocate (short-seller)

Dismantling the bull case as a skeptical short.

• What structurally breaks the money machine? The money machine is one orebody you own a quarter of and don't control. Two structural threats: (a) permanent grade decline raising Greenbushes up the cost curve — management has conceded it and the resource grade (1.6%) sits below the mined grade (1.9%), so the trend is mathematically down; (b) a renewed lithium glut — China lepidolite (Jianxiawo can restart), African spodumene (Zimbabwe/Mali), and DLE brine all add low-cost supply; lithium has no scarcity moat, only a cost-curve, and IGO's slice is worsening.
• Revenue concentration / what if it shifts? ~All value in Greenbushes, ~all geography in WA, offtake concentrated in two converters (one, Tianqi, is the controlling JV partner — a conflict in any dispute). Concentration is total.
• Why the moat is weaker than bulls think: the moat belongs to the orebody, shared three ways, and is eroding with depth. IGO's holding-company "moat" is zero. A 24.99% non-controlling stake at a public multiple is structurally inferior to Albemarle/Tianqi's direct, controlling positions.
• Most dangerous competitor bulls underestimate: not a rival miner — it's the marginal Chinese/African low-cost tonne and lithium-price mean-reversion itself. The bear doesn't need IGO to fail operationally; it just needs spodumene to revert to US$1,000 and the 124% re-rate unwinds.
• Worst capital-allocation moves: Western Areas (~A$1.1B at the nickel top, ~A$900M debt); Cosmos (A$500M+ → mothballed); Forrestania given away for A$0; Kwinana (A$605M impaired, "just not working"). A track record of value destruction — the current team is the cleanup crew, but the institutional capital-allocation history is poor, and the finance function just lost a CFO in 29 days.
• What must hold for today's price (~A$9.25)? SC6 holds ~US$1,500+, Greenbushes' "systemic" problems prove manageable not progressive, CGP3 recovers from the fire on a reasonable timeline, and the recovery is demand-led (durable) not disruption-led (transient) — and the consensus PT (~A$8.37, i.e. below the price) is wrong to the upside.
• Valuation if growth disappoints 20–30%: if SC6 reverts ~20–30% toward US$1,150–1,300 and volumes stay grade-impaired, the FY27 "triple earnings" base case largely evaporates and IGO re-rates toward look-through net-cash-plus-a-depressed-Greenbushes — plausibly A$4–6 (vs ~A$9.25), material downside.
• Single scenario that permanently impairs the business: a permanent step-change down in Greenbushes' competitive cost position (grade decline + reliability problems becoming chronic) coinciding with a structurally oversupplied lithium market — turning the "best asset in the world" into a merely-average one. Plausibility: moderate and rising — the grade-decline part is already confirmed and geological (irreversible); the oversupply part is the historical norm for lithium.

Management Questions (ordered by information value)

1. The April-2026 guidance cut called Greenbushes' problems "systemic." With CY25 mined feed at ~1.9% Li₂O versus a 1.6% resource grade, is the feed-grade decline a permanent function of mining deeper into the orebody, and what is the expected reserve-grade and unit-cash-cost trajectory over the next five years on the current mine plan?
2. As a 24.99% non-controlling owner, what specific governance rights does IGO have over Greenbushes capex, dividend timing, and offtake pricing — and where, precisely, can Tianqi or Albemarle overrule you?
3. Tianqi has said it wants to keep control of Kwinana and not close it. What are the realistic terms, timing, and value of an IGO exit — i.e. can you actually leave, or only on Tianqi's terms, and at what price?
4. Post the 9-June-2026 CGP3 fire, what is the realistic restart timeline and capital cost, and is the ~500ktpa expansion thesis intact or impaired?
5. What is the total rehabilitation/closure liability for Nova (rehab from 2027) and Cosmos, how is it provisioned, and what is the cash-outflow profile over the next three years?
6. Four CFO events in roughly two years — including a CFO who resigned 29 days after starting — what is going on in the finance function, and are there any control, restatement, or disclosure matters investors should know about?
7. Walk me through the capital-allocation framework now: with net cash and a recovering lithium price, how do you rank dividend resumption vs. balance-sheet buffer vs. new investment — and what new investment, given the nickel exit?
8. Given the institutional history (Western Areas, Cosmos), what specifically has changed in your M&A discipline and hurdle rates so the next acquisition isn't another top-of-cycle mistake?
9. What is your through-cycle view of the spodumene price, and at what realised SC6 does Greenbushes stop earning above its cost of capital?
10. How exposed is Greenbushes' cost position to new low-cost supply (Chinese lepidolite restarts, African spodumene, DLE brine), and at what point does that compress the cost-curve advantage that defines the asset?
11. What is IGO's post-nickel identity — a single-asset lithium holding company, or a diversified critical-materials miner — and if the latter, with what and when?
12. What are the distribution mechanics from Talison/TLEA to IGO — how much of Greenbushes' cash flow actually reaches IGO shareholders vs. being retained at the JV for CGP3/other capex?
13. What is your copper/exploration strategy (Fraser Range, Silver Knight) — is there a credible second pillar, or is exploration immaterial to the investment case?
14. How should investors value IGO — you screen at 2.7x EV/EBITDA, but most of your value is equity-accounted; what is the right look-through framework?
15. What is the one risk to IGO that you think the market is currently mispricing?

---